No increased risk of dementia in patients receiving androgen deprivation therapy for prostate cancer

来源 :亚洲男性学杂志(英文版) | 被引量 : 0次 | 上传用户:heeraigyf
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Prior studies suggested that the use of androgen deprivation therapy (ADT) in patients with prostate cancer (PC) might cause the impairment of cognitive function which is one of the common symptoms of dementia; however, the association between ADT and cognitive impairment still remains controversial. This retrospective cohort study aimed to investigate the relationship between ADT and subsequent risk of dementia using a population?based dataset. Data for this study were taken from the Taiwan (China) Longitudinal Health Insurance Database 2005. We included 755 PC patients who received ADT in the study cohort and 559 PC patients who did not receive ADT in the comparison cohort. Each patient was individually tracked for a 5?year period to define those who subsequently received a diagnosis of dementia. Results show that the incidence rates of dementia per 100 person?years were 2.35 (95% confidence interval [95% CI]: 1.82–2.98) and 1.85 (95% CI: 1.35–2.48) for PC patients who received ADT and those who did not receive ADT, respectively. The adjusted hazard ratio (HR) for dementia for PC patients who received ADT was 1.21 (95% CI: 0.82–1.78, P = 0.333) compared to those who did not receive ADT. In addition, the adjusted HRs for dementia for PC patients receiving ADT with gonadotropin?releasing hormone (GnRH) agonists and without GnRH agonists were 1.39 (95%CI: 0.80–2.40, P = 0.240) and 1.13 (95% CI: 0.75–1.71, P = 0.564), respectively, compared to PC patients not receiving ADT. We concluded that there was no difference in the risk of subsequent dementia between PC patients who did and those who did not receive ADT.
其他文献
Infertility affects approximately 15% of couples who have regular intercourse with male partners for over 12-month periods,without using any contraceptives.Among these infertile couples,the male factor accounts approximately 40%-50%.A significant proporti
期刊
Emerging evidence suggests that dietary fats may inlfuence testicular function. However, most of the published literature on this ifeld has used semen quality parameters as the only proxy for testicular function. We examined the association of fat intake
This study examined the effects of melatonin on leptin?induced changes in sperm parameters in adult rats. Five groups of Sprague?Dawley rats were treated with either leptin or leptin and melatonin or melatonin for 6 weeks. Leptin was given daily via the i
Dear Editor,rnThe incidence of male infertility is approximately 10%;1 however,the causes of nonobstructive azoospermia (NOA) remain elusive.2,3 Recent studies into this type of idiopathic male infertility have focused on meiotic prophase Ⅰ.4-6 Here,we re
期刊
Once-daily tadalafil administration has been well established;however,studies about tadalafil once-daily treatment in the Chinese population are lacking.In this phase 4,postmarketing study,we ascertained the long-term safety and effectiveness of tadalafil
Gonadotropin therapy is commonly used to induce virilization and spermatogenesis in male isolated hypogonadotropic hypogonadism (IHH) patients.In clinical practice,5.6%-15.0% of male IHH patients show poor responses to gonadotropin treatment;therefore,tes
Semen from 5210 sperm bank donors was analyzed and trends in semen quality were evaluated at Shandong Human Sperm Bank between 2008 and 2014. After 2–7 days of abstinence, semen samples were collected. Measurements of semen volume, sperm concentration, sp